D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AKBA holding history
Akebia Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKBA overviewAll 13F holders of AKBAFull Q2 2026 holdings
- Shares (Q2 2026)
- 87,722
- Value
- $100.0K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 87,722 | $100.0K | <0.1% | +71,616+444.7% | Added | Holders |
| Q1 2026 | 16,106 | $22.4K | <0.1% | +584+3.8% | Added | Holders |
| Q4 2025 | 15,522 | $25.0K | <0.1% | −23,604−60.3% | Reduced | Holders |
| Q3 2025 | 39,126 | $106.8K | <0.1% | −179,963−82.1% | Reduced | Holders |
| Q2 2025 | 219,089 | $797.5K | <0.1% | +145,928+199.5% | Added | Holders |
| Q1 2025 | 73,161 | $140.5K | <0.1% | −9,500−11.5% | Reduced | Holders |
| Q4 2024 | 82,661 | $157.1K | <0.1% | −300−0.4% | Reduced | Holders |
| Q3 2024 | 82,961 | $109.5K | <0.1% | +82,961 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −22,547−100.0% | Sold out | Holders |
| Q1 2022 | 22,547 | $16.0K | <0.1% | +8,154+56.7% | Added | Holders |
| Q4 2021 | 14,393 | $33.0K | <0.1% | +14,393 | New | Holders |